PHILADELPHIA, PA — Impilo has announced pivotal collaborations with A&D Medical and PatchRx, alongside achieving ISO 13485 certification, marking significant strides in its remote patient monitoring (RPM) capabilities. These developments strengthen Impilo’s position in the healthcare technology space, enhancing patient care and operational excellence.
The integration with A&D Medical brings cellular-enabled weight scales and blood pressure monitors, delivering real-time, clinically verified data across multiple networks. These devices ensure reliable monitoring regardless of a patient’s location and provide advanced troubleshooting features.
“Partnering with Impilo allows us to extend the reach of our connected health solutions,” said Brad Wiltz, A&D Medical – Americas Business Unit Leader. “Our cellular-enabled devices ensure that patients and healthcare providers have access to accurate data, regardless of location. This collaboration is a significant step towards improving patient care and outcomes through innovative technology.”
Additionally, Impilo’s partnership with PatchRx tackles the critical issue of medication adherence, a leading cause of preventable healthcare costs and hospitalizations. PatchRx’s smart pill bottle caps turn standard prescription containers into connected devices, offering real-time data on medication tracking and enabling timely interventions.
“We’re excited to unite fronts with Impilo’s widely integrated tech stack and open up the PatchRx technology to more patient populations,” said Andrew Aertker, Co-Founder of PatchRx. “Healthcare has naturally been shifting towards more vertically integrated systems and connected technologies over the past few years. This unison is a big step in continuing to set a standard for a healthier, unified, more cost-effective future.”
Beyond these integrations, Impilo has also earned ISO 13485 certification, underscoring its commitment to quality in medical devices and services. This international standard confirms Impilo’s rigorous quality control processes and compliance with global regulatory requirements, reinforcing trust among its healthcare providers and enterprise partners.
“Throughout 2024, we’ve strategically positioned ourselves for enterprise growth by expanding our capabilities through new device integrations and strengthening our compliance framework, including ISO 13485 certification,” said Josh Stein, Founder and CEO of Impilo. “We’re energized by the opportunities ahead and our increasing ability to support more healthcare providers and improve patient outcomes in the coming year.”
With these advancements, Impilo is poised to deliver superior remote patient monitoring solutions, further contributing to healthcare innovation and efficiency.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.